Sulbenicillin Sodium

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulbenicillin Sodium
Drug Alias Namesulbenicilina磺苄青霉素钠sulbenicillinum卡达西林D (-) Sulbenicillin Sodium +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSoft Tissue Infections +[8] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSepsis +[5] 
Approved Indications in ChinaComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSepsis +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHunan Sanqing Pharmaceutical Co LtdChangsha Huamei Medical Technology Co LtdHunan Er-Kang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsComplicated Skin and Soft Tissue InfectionsUrinary Tract InfectionsSoft Tissue Infections +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01CA16
Related LinksWikipediaKEGG